Tag: 2026
Providers ‘have to shift’ in current environment
July 22, 2026Tracy Orzel, Managing Editor
WATERLOO, Iowa – Lisa Wells, senior vice president at Med-South and the 2026 HME Woman of the Year, shared her thoughts on everything from Medicare’s moratorium on new supplier numbers to the acceleration of third-party administrators – and the need, through it all, to be open to change.
HME News: What is one area providers cannot afford to overlook right now?
Lisa Wells: If you don’t have billing numbers, it’s all irrelevant. (Med-South is) in growth mode, so...
MedPAC: Medicare Advantage now reaches 55% of eligible beneficiaries
July 20, 2026HME News Staff
WASHINGTON – The Medicare Payment Advisory Committee (MedPAC) has released its 2026 data book on health care spending and the Medicare program. The publication provides data on spending, demographics, beneficiary access, quality of care and other information. Data include:
Medicare spent $1 trillion on personal health care in 2024, representing 23% of national spending on personal health care. Medicare covered 16% of people in the U.S.
In February 2026, enrollment in MA plans, which...
Association leaders use State Summit to align TPA response
June 19, 2026HME News Staff
WATERLOO, Iowa - VGM’s recent State Leader Summit gave association leaders something they rarely get: A chance to sit in the same room at a moment when the home medical equipment (HME) industry needs a coordinated response to the accelerating shift to third-party administrators (TPAs).
In recent months, insurers in states from Tennessee to Washington state have tapped TPAs to manage their HME benefit.
“Currently, we've got the third-party administrator piece floating through...
F&P sees high, single-digit boost from recent mask launches
May 26, 2026HME News Staff
AUCKLAND, New Zealand – Fisher & Paykel Healthcare reported revenue of $802.7 million for the 2026 financial year for its Homecare product group, an 8% increased compared to the previous year.
Revenue from obstructive sleep apnea (OSA) masks was up 7%.
“Our latest mask ranges, the F&P Solo and F&P Nova, continued to drive OSA mask growth,” said Lewis Gradon, managing director and CEO. “Our newest offering, the F&P Nova Nasal, was launched in the United...
NCPA supports re-introduction of Monopolies Act
May 18, 2026HME News Staff
ALEXANDRIA, Va. – The National Community Pharmacists Association (NCPA) supports the re-introduction of the Patients Before Monopolies Act, which would force companies that own health insurers or pharmacy benefit managers to divest their pharmacy businesses within three years. The act, first introduced in December 2024, has been reintroduced in both the House and Senate. “PBMs have a choice – operate as a PBM or operate as a pharmacy, but you can’t have it both ways,”...
Accendra Health reports Q1, announces $1.5B optimization
May 11, 2026HME News Staff
RICHMOND, Va. – Accendra Health reported $627.8 million for the first quarter of 2026 vs. $673.9 million for the same period last year. Adjusted EBITDA was $58.4 million vs. $96 million.
Unless otherwise noted, the results reflect Accendra’s continuing operations, which represent what was previously the Patient Direct segment and certain functional operations. The company ended the fourth quarter of 2025 by selling its Products & Healthcare Services (P&HS) business to Platinum...
McKesson says it is well-positioned going into 2027
May 11, 2026HME News Staff
IRVING, Texas – McKesson Corp. has reported consolidated revenues of $96.3 billion for the fourth quarter of fiscal year 2026, a 6% increase. It reported revenues of $403.4 billion for the full year, a 12% increase.
Fourth quarter highlights:
Earnings per diluted share of $13.71 increased $3.70.
Adjusted Earnings per diluted share of $11.69 increased 16%.
McKesson entered into a $2.25 billion accelerated share repurchase program.
McKesson’s board of directors approved a...
Medline positions for sustained growth
May 11, 2026HME News Staff
NORTHFIELD, Ill. – Medline reported net sales of $7.4 billion for the first quarter of 2026, a 10.7% increase. Net income was $239 million, a 25.8% decrease.
Other financial results:
Adjusted EBITDA of $776 million, a decrease of 10.6%.
Diluted earnings per share and adjusted diluted EPS were $0.16 and $0.33, respectively.
Net cash provided by operating activities in the first quarter 2026 was $412 million, driven by net income, excluding the impact of non-cash items, partially...
Inogen credits ‘power of our strategy’
May 7, 2026HME News Staff
BEVERLY, Mass. - Inogen reported total revenue of $85.1 million for the first quarter of 2026, a 3.4% increase compared to the prior-year period, ahead of the company’s expectations.
Other financial results
Total gross margin was 44.5% in the first quarter of 2026 compared to 44.2% in the prior-year period. Adjusted gross margin improved by 30 basis points to 44.7% compared to 44.4% in the prior-year period due to cost improvements in the total cost of revenue.
GAAP net loss for...
NCART, iNRRTS, US Rehab issue call to action leading up to Product Expo
May 5, 2026HME News Staff
WASHINGTON – The National Coalition for Assistive Rehab Technology (NCART) the International Registry of Rehabilitation Technology Suppliers (iNRRTS) and U.S. Rehab are asking industry stakeholders to send brief, pre-written emails to their legislators asking them to attend the upcoming Complex Rehab Technology (CRT) Product Expo in Washington, D.C., on May 13. Using NCART’s VoterVoice platform, the organizations say the process is quick and straightforward, requiring stakeholders to...